Presentation Information
[P-56]タンデムエピトープ抗原を用いた新規CTL誘導型ユニバーサルSARS-CoV-2ワクチンの開発
*Yuji Masuta1, Shokichi Takahama1, Rigel Suzuki2, Takuto Nogimori1, Masayuki Aboshi3, Daisuke Kawakami3, Kaoru Kono3, Takahiro Tone3, Nakata Misako3, Takashi Sekida3, Wataru Akahata3, Takasuke Fukuhara2, Takuya Yamamoto1,4,5 (1. National Institutes of Biomedical Innovation, Health and Nutrition, 2. Faculty of Medical Sciences, Kyushu Univ., 3. VLP Therapeutics Japan, Inc., 4. Graduate School of Pharmaceutical Sciences, Osaka Univ., 5. Graduate School of Medicine, Osaka Univ.)